Various growth factor and cytokine receptors

Various growth factor and cytokine receptors is a collective term used in pharmacology to describe the broad range of cell surface proteins that mediate cellular responses to mitogenic and inflammatory signals (DrugBank, DB04951). This designation is most commonly associated with drugs like pirfenidone, which exert anti-fibrotic and anti-inflammatory effects by modulating multiple signaling pathways simultaneously rather than binding to a single specific receptor (StatPearls, Pirfenidone). These receptors, including those for transforming growth factor-beta (TGF-beta), platelet-derived growth factor (PDGF), and tumor necrosis factor-alpha (TNF-alpha), are essential for regulating fibroblast activation, extracellular matrix production, and the recruitment of immune cells (PubMed, PMID: 26338787). Dysregulation of these pathways is a hallmark of chronic fibrotic diseases, such as idiopathic pulmonary fibrosis (IPF), and various inflammatory conditions (NIH, National Heart, Lung, and Blood Institute). By inhibiting the production and signaling of these diverse factors, therapeutic agents can reduce tissue scarring and inflammation. However, the broad nature of these targets can lead to systemic side effects, such as photosensitivity and gastrointestinal distress (FDA, Esbriet Label). The term reflects the pleiotropic nature of certain anti-fibrotic agents whose exact molecular targets are not fully elucidated but involve multiple cytokine and growth factor axes. In clinical practice, monitoring these pathways often involves measuring levels of specific cytokines or assessing organ function, such as lung capacity. This target group represents a significant area of research for treating diseases where multiple redundant signaling pathways drive pathology. Overall, it serves as a functional category for drugs that provide a multi-pronged approach to complex disease processes.

Other names

Growth factor receptorsCytokine receptorsPleiotropic growth factor targetsMulti-receptor complex

Inhibition of the synthesis and activity of multiple growth factors and cytokines (e.g., TGF-beta, PDGF, TNF-alpha) and their downstream signaling pathways, resulting in anti-fibrotic and anti-inflammatory effects (DrugBank, DB04951).